Bioequivalence Study Between Two Oral Formulations of Gemfibrozil Tablets
NCT00800475 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2013-08-13
Summary
The purpose of this study is to determine whether two oral formulations of Gemfibrozil Tablets are bioequivalent.
Conditions
- Bioavailability
Interventions
- DRUG
-
Gemfibrozil Tablets
Sponsors & Collaborators
-
Blu Caribe
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-07-31
- Primary Completion
- 2005-07-31
- Completion
- 2005-09-30
More Related Trials
-
Bioequivalence Study of Ezetimibe Tablets Under Fed Conditions in Healthy Subjects
NCT05481385 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase 1, Single Dose, Crossover Study to Determine Bioequivalence and to Investigate Food Effect
NCT00807118 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Ezetimibe Tablets Under Fasting Conditions in Healthy Subjects
NCT05381870 ·Status: UNKNOWN ·Phase: PHASE1
-
Bioequivalence Study Of Pediatric Appropriate Formulation
NCT00758004 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Gefitinib Tablets Under Fed Conditions
NCT03050177 ·Status: COMPLETED ·Phase: PHASE1
-
Meloxicam 15 mg Tablets Under Fasting Conditions
NCT00840476 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy People to See How Zongertinib is Taken up Into the Blood When Given as Tablets Made by Two Different Manufacturers
NCT06360081 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Bioequivalence of Fezolinetant Formulations in Healthy Female Participants
NCT04277624 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Establish The Equivalence Of 2 Palbociclib (PD-0332991) Formulations To The Intended Final Market Product
NCT01906125 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of Dotilavir Sodium Tablets in Healthy Subjects in the Fasting and Fed State
NCT05168176 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of the Safety, Tolerability, and Bioequivalence of Orally Administered Venglustat in Healthy Adult Participants
NCT06418607 ·Status: COMPLETED ·Phase: PHASE1
-
Oral Bio-equivalence Study
NCT05145621 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Generic Celecoxib 200 mg Capsules
NCT06337422 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule, Under Fed Conditions
NCT01513057 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules.
NCT04390776 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of Ezetimibe Tablets in Healthy Subjects
NCT04814589 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Demonstrate the Equivalence of the Tofacitinib Oral Solution to the Tablet Formulation in Healthy Participants.
NCT04111614 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Comparing Amounts of 2 Different Forms of Tafamidis (PF-6291826) in the Blood
NCT03266705 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioequivalence Study Comparing Two Different Tafamidis Formulations
NCT02217813 ·Status: COMPLETED ·Phase: PHASE1
-
To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 300 mg Capsule Fed Conditions
NCT00882154 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare Two Forms of Study Medicine Tafamidis in the Blood in Healthy Adults
NCT06705569 ·Status: COMPLETED ·Phase: PHASE1
-
Study Comparing Gelatine Capsule 40 mg D961H and HPMC Capsule in Japanese Healthy Males
NCT00930215 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Bioequivalence of Two Different Forms of Entrectinib (Forms A and C) Under Fasted Conditions in Healthy Subjects
NCT03796013 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting Conditions
NCT00616681 ·Status: COMPLETED ·Phase: NA
-
Food Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg
NCT00650169 ·Status: COMPLETED ·Phase: PHASE1